Camila 0.35 MG tablet 28S
Ended Awarded Last action
- Contract number
- SPE2DR26FV8WB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,744
Award facts
- Contract value 100% obligated
- $16,743.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,743.68 to AmerisourceBergen Drug Corp for the supply of Camila 0.35 mg tablets (28-count packaging) on January 22, 2026, with an ultimate completion date of January 23, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 and extending through December 2031.
AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor for federal medical procurement, particularly serving military and veteran healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The parent company, Cencora, Inc. (operating under the AmerisourceBergen brand), maintains significant contracting relationships with the Defense Logistics Agency and Department of Veterans Affairs, demonstrating established capability in fulfilling government requirements for essential pharmaceutical commodities needed by military treatment facilities and federal healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26FV8WB?
SPE2DR26FV8WB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FV8WB worth?
The government has obligated $16,744 on SPE2DR26FV8WB.
Is contract SPE2DR26FV8WB an order under another contract?
Yes. SPE2DR26FV8WB is a delivery order under SPE2DR25D7056, an indefinite delivery contract.
Was contract SPE2DR26FV8WB competed?
The extent of competition for SPE2DR26FV8WB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award